Trupanion (NASDAQ:TRUP) Reaches New 12-Month High – What’s Next?

Shares of Trupanion, Inc. (NASDAQ:TRUP) reached a new 52-week high on Friday . The stock traded as high as $49.67 and last traded at $49.37, with a volume of 238379 shares. The stock had previously closed at $47.06.

Analysts Set New Price Targets

A number of research firms recently commented on TRUP. William Blair assumed coverage on shares of Trupanion in a research note on Friday, July 19th. They set an “outperform” rating on the stock. Northland Securities raised their target price on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a research note on Thursday, September 19th. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Bank of America boosted their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Finally, Stifel Nicolaus raised their target price on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.83.

Trupanion Stock Up 4.2 %

The firm has a market cap of $2.07 billion, a PE ratio of -110.00 and a beta of 1.73. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The business has a fifty day moving average price of $42.87 and a two-hundred day moving average price of $33.19.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. During the same period in the prior year, the firm earned ($0.33) earnings per share. The firm’s revenue was up 16.3% compared to the same quarter last year. On average, analysts anticipate that Trupanion, Inc. will post -0.34 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Fawwad Qureshi sold 624 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,764 shares of company stock worth $405,238. Insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC raised its stake in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Trupanion in the second quarter valued at $162,000. Oppenheimer Asset Management Inc. bought a new position in shares of Trupanion in the second quarter valued at about $235,000. Handelsbanken Fonder AB bought a new position in shares of Trupanion in the third quarter valued at about $248,000. Finally, Bayesian Capital Management LP bought a new stake in Trupanion during the 1st quarter worth about $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.